Concepedia

Publication | Open Access

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

DOIFull Paper Access

140

Citations

37

References

2018

Year

Petr Novák, Reinhold Schmidt, Eva Kontseková, Branislav Kováčech, Tomáš Smolek, Stanislav Katina, Ľubica Fialová, Michal Prčina, Vojtech Parrák, Peter Dal‐Bianco,
Alzheimer s Research & Therapy

References

YearCitations

Page 1